No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Cocrystal Pharma (COCP) Gets a Buy From Noble Financial
Cocrystal Pharma | 10-K: FY2024 Annual Report
Cocrystal Pharma Reported Unrestricted Cash as of Dec 31 of $9.9M >COCP
Cocrystal Pharma 2024 Loss/Shr $1.72 >COCP
Cocrystal Pharma Reports 2024 Financial Results and Provides Updates on Its Antiviral Drug-Development Programs
Express News | Cocrystal Pharma FY Basic EPS USD -1.72